Analyst Ratings:
Canadian Analyst Ratings
AGF Management Ltd. (AGF.B:CA) — TD Securities lowered its price target to $20.00 from $23.00 and maintained a Buy rating.
AGF Management Ltd. (AGF.B:CA) — BMO lowered its price target to $19.00 from $21.00; no rating was provided.
AGF Management Ltd. (AGF.B:CA) — Desjardins Securities lowered its price target to $21.00 from $23.00 and maintained a Buy rating.
AGF Management Ltd. (AGF.B:CA) — RBC Capital lowered its price target to $20.00 from $23.00 and maintained a Sector Perform rating.
BlackBerry Limited (BB:CA) — CIBC lowered its price target to $18.00 and maintained an Outperform rating; the previous target was not provided.
Cameco Corp. (CCO:CA) — RBC Capital maintained an Outperform rating and a $184.00 price target.
Cameco Corp. (CCO:CA) — TD Securities maintained a Buy rating and a $190.00 price target.
Canadian National Railway Co. (CNR:CA) — RBC Capital lowered its price target to $198.00 from $205.00 and maintained an Outperform rating.
Canadian National Railway Co. (CNR:CA) — CIBC maintained an Outperform rating and a $198.00 price target.
Canadian Pacific Kansas City Ltd. (CP:CA) — RBC Capital raised its price target to $146.00 from $145.00 and maintained an Outperform rating.
Dexterra Group Inc. (DXT:CA) — Raymond James raised its price target to $20.00 from $18.50 and maintained an Outperform rating.
Gildan Activewear Inc. (GIL:CA) — TD Securities lowered its price target to $76.00 from $113.00 and maintained a Buy rating.
Ivanhoe Electric Inc. (IE:CA) — Raymond James lowered its price target to $20.00 from $21.00 and maintained an Outperform rating.
Kinross Gold Corp. (K:CA) — Desjardins Securities lowered its price target to $53.00 from $58.00 and maintained a Buy rating.
Kinross Gold Corp. (K:CA) — Scotiabank lowered its price target to $55.00 from $58.00 and maintained a Sector Outperform rating.
Kinross Gold Corp. (K:CA) — Canaccord Genuity lowered its price target to $66.50 from $73.50 and maintained a Buy rating.
Kinross Gold Corp. (K:CA) — BMO lowered its price target to $48.00 from $49.00 and maintained an Outperform rating.
Kinross Gold Corp. (K:CA) — TD Securities lowered its price target to $49.50 from $56.50 and maintained a Buy rating.
Orezone Gold Corp. (ORE:CA) — National Bank raised its price target to $4.25 from $4.00 and maintained an Outperform rating.
Slate Grocery REIT (SGR.U:CA) — ATB Cormark lowered its price target to $8.00 from $13.00 and maintained an Underperform rating.
Slate Grocery REIT (SGR.U:CA) — CIBC lowered its price target to $8.25 from $12.00 and maintained a Neutral rating.
Stingray Group Inc. (RAY:CA) — CIBC maintained an Outperform rating and a $19.00 price target.
Thinkific Labs Inc. (THNC:CA) — ATB Cormark raised its price target to $3.25 from $2.25 and maintained an Outperform rating.
Total Energy Services Inc. (TOT:CA) — RBC Capital initiated coverage with a Sector Perform rating and a $41.00 price target.
Total Energy Services Inc. (TOT:CA) — ATB Cormark raised its price target to $42.00 from $36.50 and maintained an Outperform rating.
US Analyst Ratings
3M (MMM) — Wells Fargo & Company set a price target of $195.00 for the stock.
Aardvark Therapeutics (AARD) — Royal Bank Of Canada reiterated its Sector Perform rating on the stock with a price target of $6.00.
AbCellera Biologics (ABCL) — Goldman initiated coverage of the company with a Neutral rating and a price target of $13.
AC Immune (ACIU) — HC Wainwright reiterated its Buy rating on the stock.
ACADIA Pharmaceuticals (ACAD) — BMO Capital Markets reiterated its Outperform rating on the stock.
ACADIA Pharmaceuticals (ACAD) — Citigroup lowered its price target for the stock to $33.00 from $40.00 while maintaining a Buy rating.
ACADIA Pharmaceuticals (ACAD) — Needham & Company LLC reiterated its Buy rating on the stock with a price target of $41.00.
ACADIA Pharmaceuticals (ACAD) — TD Cowen reiterated its Buy rating on the stock.
Afya (AFYA) — Bradesco Corretora upgraded the stock to Outperform and set a price target of $17.00.
Alexandria RE (ARE) — JP Morgan downgraded the stock from Neutral to Underweight and set a price target of $56.
Alexandria Real Estate Equities (ARE) — Jefferies Financial Group lowered its price target for the stock to $46.00 from $47.00 while maintaining a Hold rating.
Alight (ALIT) — DA Davidson lowered its price target for the stock to $22.00 from $32.00 while maintaining a Buy rating.
Alkami Technology (ALKT) — Citigroup reiterated its Market Outperform rating on the stock.
Alkami Technology (ALKT) — Citizens Jmp reiterated its Market Outperform rating on the stock with a price target of $24.00.
Alkami Technology (ALKT) — JP Morgan downgraded the stock from Overweight to Underweight and lowered its price target to $14.00 from $24.00.
Alkermes (ALKS) — The Goldman Sachs Group reiterated its Neutral rating on the stock with a price target of $50.00.
Almonty Industries (ALM) — The Goldman Sachs Group initiated coverage of the company with a Neutral rating and a price target of $13.00.
Americold Realty Trust (COLD) — JP Morgan upgraded the stock from Underweight to Neutral and set a price target of $16.
Angi (ANGI) — UBS Group set a price target of $14.00 for the stock.
Anheuser-Busch InBev SA/NV (BUD) — Bank of America reiterated its Buy rating on the stock.
Anheuser-Busch InBev SA/NV (BUD) — Deutsche Bank Aktiengesellschaft reiterated its Buy rating on the stock.
Anheuser-Busch InBev SA/NV (BUD) — Jefferies Financial Group reiterated its Buy rating on the stock.
Anheuser-Busch InBev SA/NV (BUD) — JPMorgan Chase & Co. reiterated its Buy rating on the stock.
Anheuser-Busch InBev SA/NV (BUD) — UBS Group reiterated its Buy rating on the stock.
Arcturus Therapeutics (ARCT) — BTIG Research lowered its price target for the stock to $20.00 from $23.00 while maintaining a Buy rating.
Arcturus Therapeutics (ARCT) — Cantor Fitzgerald reiterated its Overweight rating on the stock.
Arcturus Therapeutics (ARCT) — Citigroup upgraded the stock from Neutral to Buy and raised its price target to $20.00 from $8.00.
Ares Management (ARES) — Piper Sandler initiated coverage of the company with an Overweight rating and a price target of $150.
Arrowhead (ARWR) — Goldman resumed coverage of the company with a Neutral rating and a price target of $74.
Arthur J. Gallagher & Co. (AJG) — Cantor Fitzgerald reiterated its Neutral rating on the stock.
Arthur J. Gallagher & Co. (AJG) — Keefe, Bruyette & Woods reiterated its Market Perform rating on the stock.
Arthur J. Gallagher & Co. (AJG) — Piper Sandler reiterated its Overweight rating on the stock.
Arthur J. Gallagher & Co. (AJG) — Royal Bank Of Canada lowered its price target for the stock to $290.00 from $310.00 while maintaining a Outperform rating.
Arthur J. Gallagher & Co. (AJG) — Wells Fargo & Company lowered its price target for the stock to $291.00 from $296.00 while maintaining a Overweight rating.
Aurora Innovation (AUR) — Canaccord Genuity Group raised its price target for the stock to $17.00 from $15.00 while maintaining a Buy rating.
Aurora Innovation (AUR) — Needham & Company LLC reiterated its Buy rating on the stock with a price target of $13.00.
Aurora Innovation (AUR) — The Goldman Sachs Group raised its price target for the stock to $7.00 from $6.00 while maintaining a Neutral rating.
Autodesk (ADSK) — UBS Group reiterated its Buy rating on the stock.
Bank of America (BAC) — Jefferies Financial Group lowered its price target for the stock to $70.00 from $75.00 while maintaining a Buy rating.
Beta Bionics (BBNX) — Truist Financial raised its price target for the stock to $28.00 from $23.00 while maintaining a Buy rating.
Blue Owl Capital (OWL) — Citigroup reiterated its Market Outperform rating on the stock.
Blue Owl Capital (OWL) — HSBC set a price target of $17.00 for the stock.
BlueLinx (BXC) — Citigroup initiated coverage of the company with a Market Perform rating.
BlueLinx (BXC) — Citizens initiated coverage of the company with a Market Perform rating.
BMW Group (BMWKY) — HSBC Securities downgraded the stock from Buy to Hold.
Booking (BKNG) — BTIG Research reiterated its Buy rating on the stock with a price target of $250.00.
Booking (BKNG) — Citigroup reiterated its Market Perform rating on the stock.
Brixmor Property Group (BRX) — Mizuho lowered its price target for the stock to $30.00 from $33.00 while maintaining a Outperform rating.
BWX Technologies (BWXT) — BNP Paribas Exane lowered its price target for the stock to $165.00 from $190.00 while maintaining a Neutral rating.
Cal-Maine Foods (CALM) — BMO Capital Markets reiterated its Market Perform rating on the stock and lowered its price target to $75.00 from $83.00.
Canadian Pacific Kansas City (CP) — Royal Bank Of Canada reiterated its Outperform rating on the stock.
CareDx (CDNA) — BTIG Research raised its price target for the stock to $74.00 from $60.00 while maintaining a Buy rating.
Carlyle Group (CG) — Piper Sandler initiated coverage of the company with an Overweight rating and a price target of $54.
Carnival (CCL) — JPMorgan Chase & Co. lowered its price target for the stock to $39.00 from $43.00 while maintaining a Overweight rating.
Carnival (CCL) — Susquehanna lowered its price target for the stock to $28.00 from $33.00 while maintaining a Positive rating.
Carrier Global (CARR) — Wells Fargo & Company set a price target of $67.00 for the stock and changed its rating from Negative to Overweight.
Cinemark (CNK) — Morgan Stanley lowered its price target for the stock to $40.00 from $42.00 while maintaining a Equal Weight rating.
Cintas (CTAS) — Robert W. Baird changed its price target for the stock to $222.00 from $214.00 with an Outperform rating.
Cintas (CTAS) — Royal Bank Of Canada reiterated its Sector Perform rating on the stock with a price target of $206.00.
Cintas (CTAS) — Truist Financial raised its price target for the stock to $230.00 from $225.00 while maintaining a Buy rating.
Cintas (CTAS) — UBS Group reiterated its Buy rating on the stock and raised its price target to $235.00 from $230.00.
CNB Financial (CCNE) — Piper Sandler initiated coverage of the company with an Overweight rating and a price target of $38.
Colliers International Group (CIGI) — BMO Capital Markets reiterated its Outperform rating on the stock.
Comcast (CMCSA) — Citigroup lowered its price target for the stock to $27.50 from $30.00 while maintaining a Buy rating.
Comcast (CMCSA) — KeyCorp downgraded the stock from Sector Weight to Underweight and set a price target of $18.00.
CoreWeave (CRWV) — JP Morgan upgraded the stock from Neutral to Overweight and raised its price target to $125.00 from $120.00.
Corteva (CTVA) — Oppenheimer reiterated its Outperform rating on the stock with a price target of $95.00.
Cracker Barrel Old Country Store (CBRL) — Bank of America reiterated its Underperform rating on the stock with a price target of $48.00.
CSX (CSX) — Royal Bank Of Canada lowered its price target for the stock to $53.00 from $54.00 while maintaining a Outperform rating.
Cummins (CMI) — Bank of America lowered its price target for the stock to $600.00 from $731.00.
Darden Restaurants (DRI) — TD Cowen reiterated its Hold rating on the stock with a price target of $215.00.
Deere & Company (DE) — Bank of America raised its price target for the stock to $715.00 from $667.00.
Delta Air Lines (DAL) — UBS Group raised its price target for the stock to $105.00 from $99.00 while maintaining a Buy rating.
Dollar General (DG) — HSBC Securities upgraded the stock from Hold to Buy and raised its price target to $160.00 from $125.00.
Dover (DOV) — Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $229.00.
DraftKings (DKNG) — Citizens reiterated its Market Outperform rating on the stock and lowered its price target to $35 from $37.
Dropbox (DBX) — Citigroup downgraded the stock from Neutral to Sell and lowered its price target to $29.00 from $33.00.
Dycom Industries (DY) — Cantor Fitzgerald reiterated its Overweight rating on the stock with a price target of $476.00.
Dynatrace (DT) — Oppenheimer reiterated its Outperform rating on the stock and raised its price target to $71 from $60.
EastGroup (EGP) — JP Morgan upgraded the stock from Neutral to Overweight and set a price target of $231.
Eaton (ETN) — Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $503.00.
eBay (EBAY) — Arete Research lowered its price target for the stock to $111.00 from $113.00 while maintaining a Neutral rating.
Edison International (EIX) — UBS Group reiterated its Neutral rating on the stock with a price target of $57.00.
Elicio Therapeutics (ELTX) — B. Riley Financial set a price target of $8.00 for the stock while maintaining a Buy rating.
Energy Services of America (ESOA) — Roth Capital initiated coverage of the company with a Buy rating and a price target of $20.
Entera Bio (ENTX) — Guggenheim initiated coverage of the company with a Buy rating.
Essential Properties Realty Trust (EPRT) — Scotiabank lowered its price target for the stock to $30.00 from $33.00 while maintaining a Sector Outperform rating.
Ethos Technologies Inc. Class A Common Stock (LIFE) — Bank of America reiterated its Buy rating on the stock with a price target of $38.00.
Etsy (ETSY) — Arete downgraded the stock from Buy to Neutral and set a price target of $81.
Etsy (ETSY) — Arete Research set a price target of $81.00 for the stock and changed its rating from Buy to Neutral.
Eupraxia Pharmaceuticals (EPRX) — Stifel Nicolaus set a price target of $25.00 for the stock.
Eupraxia Pharmaceuticals (EPRX) — Wedbush initiated coverage of the company with an Outperform rating and a price target of $17.
Everpure (P) — Citigroup raised its price target for the stock to $160.00 from $130.00 while maintaining a Buy rating.
Everpure (P) — Evercore reiterated its Outperform rating on the stock with a price target of $145.00.
Everpure (P) — Guggenheim reiterated its Buy rating on the stock with a price target of $150.00.
Everpure (P) — Lake Street Capital raised its price target for the stock to $130.00 from $120.00 while maintaining a Buy rating.
Everpure (P) — Morgan Stanley raised its price target for the stock to $137.00 from $119.00 while maintaining a Overweight rating.
Everpure (P) — Needham & Company LLC raised its price target for the stock to $150.00 from $140.00 while maintaining a Buy rating.
Everpure (P) — Northland Securities set a price target of $167.00 for the stock.
Everpure (P) — Piper Sandler raised its price target for the stock to $162.00 from $133.00 while maintaining a Overweight rating.
Everpure (P) — Wedbush reiterated its Outperform rating on the stock with a price target of $130.00.
Everpure (P) — Wells Fargo & Company raised its price target for the stock to $145.00 from $135.00 while maintaining a Overweight rating.
Federal Realty Investment Trust (FRT) — Mizuho lowered its price target for the stock to $117.00 from $130.00 while maintaining a Outperform rating.
Federal Realty Investment Trust (FRT) — UBS Group set a price target of $117.00 for the stock.
Fervo Energy (FRVO) — Johnson Rice initiated coverage of the company with a Buy rating and a price target of $35.
Fervo Energy (FRVO) — Sanford C. Bernstein reiterated its Outperform rating on the stock with a price target of $47.00.
Fifth Third Bancorp (FITB) — Jefferies Financial Group lowered its price target for the stock to $65.00 from $70.00 while maintaining a Buy rating.
First Financial Bancorp. (FFBC) — Truist Financial set a price target of $37.00 for the stock and changed its rating from Hold to Buy.
Forgent Power Solutions (FPS) — Wells Fargo & Company set a price target of $44.00 for the stock.
Frontier Group (ULCC) — UBS Group lowered its price target for the stock to $6.00 from $7.00 while maintaining a Neutral rating.
FuelCell Energy (FCEL) — Barclays initiated coverage of the company with an Equal Weight rating and a price target of $20.
Gaming and Leisure Properties (GLPI) — JP Morgan downgraded the stock from Overweight to Neutral and set a price target of $46.
Gaming and Leisure Properties (GLPI) — Scotiabank lowered its price target for the stock to $43.00 from $49.00 while maintaining a Sector Perform rating.
General Mills (GIS) — Bank of America reiterated its Neutral rating on the stock.
General Mills (GIS) — Deutsche Bank reiterated its Hold rating on the stock and raised its price target to $34 from $33.
General Mills (GIS) — Deutsche Bank Aktiengesellschaft reiterated its Hold rating on the stock and raised its price target to $34.00 from $33.00.
General Mills (GIS) — Piper Sandler reiterated its Overweight rating on the stock.
General Mills (GIS) — Sanford C. Bernstein reiterated its Underperform rating on the stock with a price target of $30.00.
General Mills (GIS) — TD Cowen reiterated its Hold rating on the stock and raised its price target to $33 from $32.
General Motors (GM) — TD Cowen reiterated its Hold rating on the stock.
General Motors (GM) — UBS Group set a price target of $33.00 for the stock.
Getty Realty (GTY) — KeyCorp reiterated its Overweight rating on the stock with a price target of $36.00.
Gildan Activewear (GIL) — TD lowered its price target for the stock to $54.00 from $80.00 while maintaining a Buy rating.
Gildan Activewear (GIL) — TD Securities lowered its price target for the stock to $54.00 from $80.00 while maintaining a Buy rating.
Global Payments (GPN) — Loop Capital initiated coverage of the company with a Buy rating and a price target of $137.00.
Golar LNG (GLNG) — BTIG Research raised its price target for the stock to $75.00 from $70.00 while maintaining a Buy rating.
GRAIL (GRAL) — TD Cowen reiterated its Buy rating on the stock.
Harmony Biosciences (HRMY) — Oppenheimer reiterated its Outperform rating on the stock.
Hubbell (HUBB) — Wells Fargo & Company set a price target of $531.00 for the stock.
Huntington Bancshares (HBAN) — Jefferies Financial Group lowered its price target for the stock to $17.00 from $18.00 while maintaining a Hold rating.
IMAX (IMAX) — Morgan Stanley initiated coverage of the company with an Overweight rating and a price target of $63.
Immunovant (IMVT) — Citigroup reiterated its Positive rating on the stock.
Immunovant (IMVT) — HC Wainwright reiterated its Buy rating on the stock.
Insmed (INSM) — Goldman resumed coverage of the company with a Buy rating and a price target of $188.
Intel (INTC) — TD Cowen reiterated its Hold rating on the stock with a price target of $115.00.
International Paper (IP) — Argus reiterated its Buy rating on the stock with a price target of $45.00.
Intuit (INTU) — The Goldman Sachs Group reiterated its Sell rating on the stock.
Ionis Pharmaceuticals (IONS) — HC Wainwright reiterated its Buy rating on the stock with a price target of $100.00.
Ionis Pharmaceuticals (IONS) — Oppenheimer reiterated its Outperform rating on the stock with a price target of $85.00.
Iovance Biotherapeutics (IOVA) — Goldman resumed coverage of the company with a Buy rating and a price target of $15.
Jazz Pharma (JAZZ) — Goldman resumed coverage of the company with a Buy rating and a price target of $337.
JBT Marel (JBTM) — Robert W. Baird lowered its price target for the stock to $171.00 from $188.00 while maintaining a Outperform rating.
Johnson Controls International (JCI) — Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $186.00.
JPMorgan Chase & Co. (JPM) — Jefferies Financial Group lowered its price target for the stock to $365.00 from $370.00 while maintaining a Hold rating.
KeyCorp (KEY) — Jefferies Financial Group lowered its price target for the stock to $22.00 from $24.00 while maintaining a Hold rating.
Kimco Realty (KIM) — Mizuho lowered its price target for the stock to $23.00 from $25.00 while maintaining a Neutral rating.
Kimco Realty (KIM) — UBS Group set a price target of $23.00 for the stock.
Kinross Gold (KGC) — Canaccord Genuity Group lowered its price target for the stock to $47.00 from $52.00 while maintaining a Buy rating.
Kinross Gold (KGC) — Scotia lowered its price target for the stock to $39.00 from $41.00 while maintaining a Sector Outperform rating.
Kinross Gold (KGC) — Scotiabank lowered its price target for the stock to $39.00 from $41.00 while maintaining a Sector Outperform rating.
Kinross Gold (KGC) — TD lowered its price target for the stock to $35.00 from $40.00 while maintaining a Buy rating.
Kinross Gold (KGC) — TD Securities lowered its price target for the stock to $35.00 from $40.00 while maintaining a Buy rating.
Kite Realty (KRG) — JP Morgan downgraded the stock from Neutral to Underweight and set a price target of $27.
Knife River (KNF) — Oppenheimer lowered its price target for the stock to $80.00 from $90.00 while maintaining a Outperform rating.
Kodiak Sciences (KOD) — Goldman resumed coverage of the company with a Neutral rating and a price target of $36.
Kraft Heinz (KHC) — Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $32.00.
Krystal Biotech (KRYS) — Goldman resumed coverage of the company with a Buy rating and a price target of $441.
Ligand Pharmaceuticals (LGND) — HC Wainwright reiterated its Buy rating on the stock with a price target of $358.00.
Lindsay (LNN) — Stifel Nicolaus set a price target of $121.00 for the stock.
Lowe’s (LOW) — Gordon Haskett downgraded the stock from Buy to Hold and set a price target of $200.
Lumexa Imaging (LMRI) — KeyCorp initiated coverage of the company with an Overweight rating and a price target of $18.00.
LuxExperience B.V. (LUXE) — TD Cowen raised its price target for the stock to $11.00 from $9.00 while maintaining a Buy rating.
M&T Bank (MTB) — Jefferies Financial Group lowered its price target for the stock to $275.00 from $300.00 while maintaining a Buy rating.
Macerich (MAC) — JP Morgan upgraded the stock from Neutral to Overweight and set a price target of $26.
Madrigal Pharmaceuticals (MDGL) — Goldman resumed coverage of the company with a Buy rating and a price target of $704.
Maze Therapeutics (MAZE) — HC Wainwright reiterated its Buy rating on the stock with a price target of $110.00.
McDonald’s (MCD) — BMO Capital Markets reiterated its Outperform rating on the stock and lowered its price target to $310 from $335.
McDonald’s (MCD) — BTIG Research reiterated its Buy rating on the stock and lowered its price target to $295 from $350.
McDonald’s (MCD) — Evercore ISI reiterated its Outperform rating on the stock and lowered its price target to $300 from $320.
McDonald’s (MCD) — Jefferies Financial Group reiterated its Buy rating on the stock with a price target of $325.00.
McDonald’s (MCD) — JP Morgan reiterated its Overweight rating on the stock and lowered its price target to $260 from $280.
McDonald’s (MCD) — Oppenheimer reiterated its Outperform rating on the stock and lowered its price target to $295 from $325.
McDonald’s (MCD) — RBC Capital Mkts reiterated its Sector Perform rating on the stock and lowered its price target to $285 from $290.
McDonald’s (MCD) — Robert W. Baird reiterated its Neutral rating on the stock and lowered its price target to $250 from $285.
McDonald’s (MCD) — TD Cowen lowered its price target for the stock to $270.00 from $282.00 while maintaining a Hold rating.
McDonald’s (MCD) — UBS Group set a price target of $260.00 for the stock.
MediWound (MDWD) — TD Cowen reiterated its Buy rating on the stock.
MeiraGTx (MGTX) — Goldman initiated coverage of the company with a Neutral rating and a price target of $16.
Mesoblast (MESO) — Cantor Fitzgerald reiterated its Overweight rating on the stock.
Meta Platforms (META) — Citigroup reiterated its Outperform rating on the stock.
Meta Platforms (META) — Citizens Jmp raised its price target for the stock to $885.00 from $770.00 while maintaining a Market Outperform rating.
Meta Platforms (META) — JPMorgan Chase & Co. raised its price target for the stock to $920.00 from $820.00 while maintaining a Overweight rating.
Meta Platforms (META) — Loop Capital raised its price target for the stock to $955.00 from $740.00 while maintaining a Buy rating.
Meta Platforms (META) — Raymond James Financial raised its price target for the stock to $860.00 from $650.00 while maintaining a Strong-Buy rating.
Meta Platforms (META) — Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $770.00.
Meta Platforms (META) — President Capital upgraded the stock from Neutral to Buy and raised its price target to $897.00 from $660.00.
Meta Platforms (META) — Tigress Financial raised its price target for the stock to $995.00 from $945.00 while maintaining a Strong-Buy rating.
MGE Energy (MGEE) — BofA Securities initiated coverage of the company with a Neutral rating and a price target of $76.
MGM Resorts International (MGM) — Mizuho lowered its price target for the stock to $55.00 from $60.00 while maintaining a Outperform rating.
MGM Resorts International (MGM) — Susquehanna lowered its price target for the stock to $46.00 from $55.00 while maintaining a Positive rating.
MGM Resorts (MGM) — BofA Securities resumed coverage of the company with a Neutral rating and a price target of $40.
Micron Technology (MU) — Rosenblatt Securities reiterated its Buy rating on the stock with a price target of $1,500.00.
MiniMed Group (MMED) — Truist Financial initiated coverage of the company with a Buy rating and a price target of $29.00.
MiniMed (MMED) — Truist initiated coverage of the company with a Buy rating and a price target of $29.
MongoDB (MDB) — Evercore reiterated its Outperform rating on the stock.
Nebius Group N.V. (NBIS) — BNP Paribas Exane upgraded the stock from Neutral to Outperform and raised its price target to $399.00 from $260.00.
NeOnc Technologies Holdings (NTHI) — Roth Capital initiated coverage of the company with a Buy rating and a price target of $20.
NeoVolta (NEOV) — Needham & Company LLC reiterated its Buy rating on the stock with a price target of $8.00.
NETSTREIT (NTST) — Scotiabank lowered its price target for the stock to $20.00 from $22.00 while maintaining a Sector Outperform rating.
Newmark Group (NMRK) — Keefe, Bruyette & Woods reiterated its Outperform rating on the stock.
NiCE (NICE) — Royal Bank Of Canada raised its price target for the stock to $145.00 from $130.00 while maintaining a Outperform rating.
Norfolk Southern (NSC) — Royal Bank Of Canada lowered its price target for the stock to $330.00 from $360.00 while maintaining a Sector Perform rating.
Norwegian Cruise Line (NCLH) — JPMorgan Chase & Co. lowered its price target for the stock to $13.00 from $17.00 while maintaining a Neutral rating.
Norwegian Cruise Line (NCLH) — Truist Financial lowered its price target for the stock to $16.00 from $20.00 while maintaining a Hold rating.
Nuvectis Pharma (NVCT) — HC Wainwright reiterated its Buy rating on the stock with a price target of $39.00.
nVent Electric (NVT) — Wells Fargo & Company set a price target of $182.00 for the stock.
Okta (OKTA) — Bank of America raised its price target for the stock to $200.00 from $170.00 while maintaining a Neutral rating.
Okta (OKTA) — Barclays raised its price target for the stock to $215.00 from $180.00 while maintaining a Overweight rating.
Okta (OKTA) — BTIG Research reiterated its Buy rating on the stock with a price target of $219.00.
Okta (OKTA) — Citigroup reiterated its Neutral rating on the stock.
Okta (OKTA) — DA Davidson raised its price target for the stock to $235.00 from $190.00 while maintaining a Buy rating.
Okta (OKTA) — Evercore reiterated its Outperform rating on the stock with a price target of $240.00.
Okta (OKTA) — Guggenheim raised its price target for the stock to $227.00 from $188.00 while maintaining a Buy rating.
Okta (OKTA) — Jefferies Financial Group raised its price target for the stock to $240.00 from $200.00 while maintaining a Buy rating.
Okta (OKTA) — KeyCorp set a price target of $240.00 for the stock with an Overweight rating.
Okta (OKTA) — Mizuho raised its price target for the stock to $200.00 from $165.00 while maintaining a Neutral rating.
Okta (OKTA) — New Street Research set a price target of $235.00 for the stock.
Okta (OKTA) — Oppenheimer raised its price target for the stock to $227.00 from $190.00 while maintaining a Outperform rating.
Okta (OKTA) — Roth Capital raised its price target for the stock to $235.00 from $155.00 while maintaining a Buy rating.
Okta (OKTA) — Royal Bank Of Canada raised its price target for the stock to $230.00 from $195.00 while maintaining a Outperform rating.
Okta (OKTA) — Stifel Nicolaus raised its price target for the stock to $215.00 from $180.00 while maintaining a Buy rating.
Okta (OKTA) — TD Cowen raised its price target for the stock to $200.00 from $175.00 while maintaining a Hold rating.
Okta (OKTA) — Truist Financial set a price target of $235.00 for the stock.
Okta (OKTA) — Wells Fargo & Company raised its price target for the stock to $230.00 from $200.00 while maintaining a Overweight rating.
Old National Bancorp (ONB) — Wells Fargo initiated coverage of the company with an Overweight rating and a price target of $30.
ON (ONON) — Barclays raised its price target for the stock to $44.00 from $42.00 while maintaining a Overweight rating.
ON (ONON) — BMO Capital Markets raised its price target for the stock to $33.00 from $28.00 while maintaining a Market Perform rating.
ON (ONON) — Piper Sandler reiterated its Overweight rating on the stock with a price target of $45.00.
ON (ONON) — Sanford C. Bernstein reiterated its Outperform rating on the stock.
Oruka Therapeutics (ORKA) — HC Wainwright reiterated its Buy rating on the stock with a price target of $120.00.
Oruka Therapeutics (ORKA) — Wedbush reiterated its Outperform rating on the stock with a price target of $165.00.
Otis Worldwide (OTIS) — Wells Fargo & Company initiated coverage of the company with an Underweight rating and a price target of $77.00.
Parker-Hannifin (PH) — Wells Fargo & Company set a price target of $1,050.00 for the stock.
Paychex (PAYX) — BMO Capital Markets reiterated its Market Perform rating on the stock and lowered its price target to $113 from $118.
Paychex (PAYX) — Jefferies Financial Group lowered its price target for the stock to $110.00 from $120.00 while maintaining a Hold rating.
Paychex (PAYX) — JP Morgan upgraded the stock from Underweight to Neutral and raised its price target to $115.00 from $105.00.
Paychex (PAYX) — Royal Bank Of Canada reiterated its Sector Perform rating on the stock with a price target of $130.00.
Paychex (PAYX) — Stephens lowered its price target for the stock to $113.00 from $132.00 while maintaining a Equal Weight rating.
Paychex (PAYX) — Stifel Nicolaus lowered its price target for the stock to $112.00 from $130.00 while maintaining a Hold rating.
Paychex (PAYX) — UBS Group lowered its price target for the stock to $115.00 from $125.00 while maintaining a Neutral rating.
PepsiCo (PEP) — Citigroup reiterated its Neutral rating on the stock and lowered its price target to $142 from $145.
Permian Resources (PR) — Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $27.00.
Phillips Edison & Company, Inc. (PECO) — Mizuho lowered its price target for the stock to $39.00 from $43.00 while maintaining a Outperform rating.
Phillips Edison & Company, Inc. (PECO) — UBS Group set a price target of $39.00 for the stock.
Portland General Electric (POR) — KeyCorp reiterated its Sector Weight rating on the stock.
PPG Industries (PPG) — Sanford C. Bernstein reiterated its Outperform rating on the stock with a price target of $136.00.
Praxis Precision Medicines (PRAX) — HC Wainwright reiterated its Buy rating on the stock with a price target of $1,201.00.
Praxis Precision Medicines (PRAX) — Needham & Company LLC reiterated its Buy rating on the stock with a price target of $582.00.
PubMatic (PUBM) — Craig Hallum initiated coverage of the company with a Buy rating and a price target of $24.
Quanta Services (PWR) — Bernstein upgraded the stock from Market Perform to Outperform and set a price target of $775.
Quanta Services (PWR) — Sanford C. Bernstein upgraded the stock from Market Perform to Outperform and raised its price target to $775.00 from $748.00.
Quince Therapeutics (QNCX) — Rodman & Renshaw initiated coverage of the company with a Buy rating and a price target of $70.
Regency Centers (REG) — JPMorgan Chase & Co. upgraded the stock from Neutral to Overweight and set a price target of $83.00.
Regency Centers (REG) — Mizuho lowered its price target for the stock to $76.00 from $82.00 while maintaining a Neutral rating.
Regency Centers (REG) — The Goldman Sachs Group set a price target of $83.00 for the stock.
Revolution Medicines (RVMD) — Goldman resumed coverage of the company with a Buy rating and a price target of $267.
Rockwell Automation (ROK) — Wells Fargo & Company set a price target of $426.00 for the stock.
Roivant Sciences (ROIV) — Cantor Fitzgerald reiterated its Overweight rating on the stock.
Roku (ROKU) — Wedbush reiterated its Neutral rating on the stock with a price target of $155.00.
Rollins (ROL) — Piper Sandler downgraded the stock from Overweight to Neutral and set a price target of $33.
Royal Caribbean Cruises (RCL) — JPMorgan Chase & Co. raised its price target for the stock to $394.00 from $345.00 while maintaining a Overweight rating.
Royal Caribbean Cruises (RCL) — Truist Financial raised its price target for the stock to $298.00 from $297.00 while maintaining a Hold rating.
Safehold (SAFE) — JP Morgan downgraded the stock from Neutral to Underweight and set a price target of $14.
Sagimet Biosciences (SGMT) — Goldman resumed coverage of the company with a Sell rating and a price target of $7.
SailPoint (SAIL) — Truist Financial raised its price target for the stock to $27.00 from $23.00 while maintaining a Buy rating.
Scholar Rock (SRRK) — Truist Financial raised its price target for the stock to $77.00 from $76.00 while maintaining a Buy rating.
Sherwin-Williams (SHW) — Mizuho set a price target of $396.00 for the stock.
Shift4 Payments (FOUR) — Mizuho lowered its price target for the stock to $46.00 from $55.00 while maintaining a Outperform rating.
Shopify (SHOP) — Mizuho set a price target of $180.00 for the stock.
Solaris Energy Infrastructure (SEI) — Citigroup raised its price target for the stock to $100.00 from $84.00 while maintaining a Buy rating.
Solaris Energy Infrastructure (SEI) — Stifel Nicolaus raised its price target for the stock to $101.00 from $98.00 while maintaining a Buy rating.
Southwest Airlines (LUV) — UBS Group raised its price target for the stock to $53.00 from $49.00 while maintaining a Buy rating.
Spruce Biosciences (SPRB) — Citizens Jmp reiterated its Market Outperform rating on the stock with a price target of $144.00.
StandardAero (SARO) — Jefferies Financial Group set a price target of $25.00 for the stock.
Starwood Property Trust (STWD) — Citigroup reiterated its Market Outperform rating on the stock.
Stitch Fix (SFIX) — Northland Securities set a price target of $4.00 for the stock.
Stitch Fix (SFIX) — Sanford C. Bernstein reiterated its Market Perform rating on the stock with a price target of $4.00.
Stitch Fix (SFIX) — Telsey Advisory Group reiterated its Market Perform rating on the stock and lowered its price target to $3 from $5.
Stitch Fix (SFIX) — UBS Group lowered its price target for the stock to $3.50 from $4.00 while maintaining a Neutral rating.
Stitch Fix (SFIX) — William Blair downgraded the stock from Outperform to Market Perform.
Synopsys (SNPS) — BNP Paribas Exane upgraded the stock from Underperform to Neutral and set a price target of $420.
Tandem Diabetes Care (TNDM) — Truist Financial lowered its price target for the stock to $28.00 from $31.00 while maintaining a Buy rating.
Tanger Factory (SKT) — JP Morgan downgraded the stock from Overweight to Neutral and set a price target of $39.
Tarsus Pharmaceuticals (TARS) — Goldman resumed coverage of the company with a Buy rating and a price target of $116.
Tesla (TSLA) — BNP Paribas Exane lowered its price target for the stock to $268.00 from $280.00 while maintaining a Underperform rating.
Tesla (TSLA) — UBS Group reiterated its Neutral rating on the stock.
Theravance Biopharma (TBPH) — BTIG Research reiterated its Neutral rating on the stock.
TransUnion (TRU) — UBS Group lowered its price target for the stock to $80.00 from $82.00 while maintaining a Neutral rating.
Travere Therapeutics (TVTX) — Guggenheim raised its price target for the stock to $89.00 from $75.00 while maintaining a Buy rating.
Twilio (TWLO) — HSBC downgraded the stock from Hold to Reduce and set a price target of $211.00.
Tyler Technologies (TYL) — BTIG Research reiterated its Buy rating on the stock with a price target of $400.00.
UiPath (PATH) — BMO Capital Markets reiterated its Market Perform rating on the stock and lowered its price target to $15 from $18.
UiPath (PATH) — Canaccord Genuity Group lowered its price target for the stock to $14.00 from $17.00 while maintaining a Hold rating.
UiPath (PATH) — KeyCorp reiterated its Sector Weight rating on the stock.
UiPath (PATH) — New Street Research set a price target of $15.00 for the stock.
UL Solutions (ULS) — Robert W. Baird lowered its price target for the stock to $85.00 from $95.00 while maintaining a Outperform rating.
Union Pacific (UNP) — Royal Bank Of Canada set a price target of $326.00 for the stock.
United Airlines (UAL) — UBS Group raised its price target for the stock to $146.00 from $137.00 while maintaining a Buy rating.
United Rentals (URI) — Royal Bank Of Canada reiterated its Outperform rating on the stock with a price target of $1,323.00.
United Therapeutics (UTHR) — Goldman initiated coverage of the company with a Sell rating and a price target of $321.
Vail Resorts (MTN) — Mizuho lowered its price target for the stock to $160.00 from $174.00 while maintaining a Outperform rating.
Vail Resorts (MTN) — Stifel Nicolaus lowered its price target for the stock to $161.00 from $167.00 while maintaining a Buy rating.
Versant (VSNT) — Citigroup initiated coverage of the company with a Buy rating and a price target of $41.
Vertiv (VRT) — Wells Fargo & Company initiated coverage of the company with an Overweight rating and a price target of $340.00.
VICI Properties (VICI) — JP Morgan downgraded the stock from Overweight to Neutral and set a price target of $30.
VICI Properties (VICI) — Scotiabank lowered its price target for the stock to $26.00 from $29.00 while maintaining a Sector Perform rating.
Viking (VIK) — Truist Financial lowered its price target for the stock to $98.00 from $102.00 while maintaining a Buy rating.
W.P. Carey (WPC) — Scotiabank lowered its price target for the stock to $68.00 from $76.00 while maintaining a Sector Perform rating.
Welltower (WELL) — JP Morgan upgraded the stock from Neutral to Overweight and set a price target of $260.
Western Union (WU) — Citigroup reiterated its Neutral rating on the stock.
WEX (WEX) — Deutsche Bank Aktiengesellschaft reiterated its Hold rating on the stock.
Wintrust Fin (WTFC) — Wells Fargo initiated coverage of the company with an Equal Weight rating and a price target of $160.
Worthington Enterprises (WOR) — Canaccord Genuity Group raised its price target for the stock to $75.00 from $67.00 while maintaining a Buy rating.
Yum! Brands (YUM) — Argus downgraded the stock from Buy to Hold.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.